Trademark: 87409880
Word
CUTECELL
Status
Registered
Status Code
700
Status Date
Tuesday, July 12, 2022
Serial Number
87409880
Registration Number
6789726
Registration Date
Tuesday, July 12, 2022
Mark Type
4000
Filing Date
Thursday, April 13, 2017
Published for Opposition
Tuesday, August 22, 2017

Trademark Owner History
RegenLab USA LLC - Original Registrant

Classifications
5 Pharmaceutical and veterinary preparations, namely, solutions for application on and under tissue, bone and organ for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontum growth and bone, organ or tissue regeneration; sanitary preparations for medical purposes; adjuvants for medical purposes; biological preparations for medical purposes, namely, platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid or any combinations thereof; pharmaceutical skin lotions; tissues impregnated with pharmaceutical lotions; medical dressings; surgical cloth tissues; medicated skin care preparations; pharmaceutical products, preparations and substances for the treatment of damaged skin and tissue; products and preparations for medical purposes for cleaning the skin; solution kits for reconstituting allograft tissue; cells for medical or clinical purposes; all-purpose disinfectants; disinfectants for hygiene purposes; kits containing chemical reagents used for medical diagnosis; plant extracts, and human and animal tissue and cells in the nature of cultures, grafts and fresh cells, for medical and veterinary use
10 Medical devices, namely, medical tubes, vials, jars, bags, pouches, cartridges, bottles, cylinders or pods, syringes, needles, holders, gels, connectors, tourniquets, plaster, pads, masks, pliers, creams, spatulas, flasks, discs, dispensers, nozzles, stoppers, adapters, cannulas, transfer devices, ampoules, backstops, anticoagulants, coagulation activators, hyaluronic acid and chitosan, sold as a unit, intended for the preparation of platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid, chitosan or any combinations thereof; kits intended for tissue and cellular regeneration, rejuvenation, healing and repair comprised of receptacles, namely, medical tubes, vials, jars, bags, pouches, cartridges, bottles, cylinders or pods, syringes and needles for regenerative medicine, isolation and application of platelets and cells, for example from blood, fat, bone marrow, stem cells and other tissue; surgical apparatus and instruments for medical, dental or veterinary use; surgical and medical apparatus and instruments, namely, tubes, containers, syringes, needles, for use in dentistry, orthopedics, cosmetics, esthetics, general surgery, ophthalmology, mesotherapy, cardiovascular, thoracic, transplantation, head and neck, oral, bone, cartilage, tendon, implant, gastrointestinal, orthopedic, neurosurgical, facial, face-lift and plastic surgery; centrifuges for medical purposes; suture material; cases fitted for medical instruments; receptacles for applying medicines, namely, medical containers, cannula, syringes, tubes, infusion and injection devices for administering drugs, platelet-rich plasma, hyaluronic acid, and hydrogels; medical tubing for administering drugs, platelet-rich plasma, hyaluronic acid and hydrogels; syringes for medical use; containers specially adapted for storing tissue and biological samples for medical purposes; medical instruments, namely, surgical instruments for facilitating the identification, separation or removal of biological tissue; medical apparatus used for taking blood; medical apparatus used for separating blood components for medical purposes; medical instruments used for filtering blood and blood components; medical apparatus used for introducing pharmaceutical preparations into the human body; medical devices, namely, surgical instruments for biological tissues; medical apparatus intended for the preparation of platelet concentrate, glycosaminoglycan and polysaccharide hydrogels
CUTE CELL

Trademark Events
Mar 27, 2023
Teas Change Of Correspondence Received
Mar 27, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 27, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 10, 2023
Teas Change Of Correspondence Received
Jan 10, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Jan 10, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 10, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 12, 2022
Exparte Appeal Terminated
Jul 12, 2022
Notice Of Registration Confirmation Emailed
Jul 12, 2022
Registered-Principal Register
Jun 4, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 3, 2022
Allowed Principal Register - Sou Accepted
May 31, 2022
Teas/Email Correspondence Entered
May 31, 2022
Correspondence Received In Law Office
May 26, 2022
Teas Request For Reconsideration Received
May 4, 2022
Jurisdiction Restored To Examining Attorney
Apr 5, 2022
Jurisdiction Restored To Examining Attorney
Jan 28, 2022
Notification Of Action Denying Req For Recon E-Mailed
Jan 28, 2022
Action Denying Req For Recon E-Mailed
Jan 28, 2022
Su - Action Continuing Final - Written
Jan 18, 2022
Teas/Email Correspondence Entered
Jan 18, 2022
Correspondence Received In Law Office
Jan 10, 2022
Teas Request For Reconsideration Received
Jan 11, 2022
Ex Parte Appeal-Instituted
Jan 11, 2022
Jurisdiction Restored To Examining Attorney
Jan 11, 2022
Exparte Appeal Received At Ttab
Jul 9, 2021
Notification Of Final Refusal Emailed
Jul 9, 2021
Final Refusal E-Mailed
Jul 9, 2021
Su - Final Refusal - Written
Jun 17, 2021
Teas/Email Correspondence Entered
Jun 17, 2021
Correspondence Received In Law Office
Jun 17, 2021
Assigned To Lie
Mar 30, 2021
Teas Response To Office Action Received
Sep 30, 2020
Notification Of Non-Final Action E-Mailed
Sep 30, 2020
Non-Final Action E-Mailed
Sep 30, 2020
Su - Non-Final Action - Written
Sep 19, 2020
Statement Of Use Processing Complete
Sep 17, 2020
Use Amendment Filed
Sep 17, 2020
Teas Statement Of Use Received
Apr 21, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 20, 2020
Sou Extension 5 Granted
Apr 14, 2020
Sou Extension 5 Filed
Apr 14, 2020
Sou Teas Extension Received
Oct 16, 2019
Notice Of Approval Of Extension Request E-Mailed
Oct 14, 2019
Sou Extension 4 Granted
Oct 14, 2019
Sou Extension 4 Filed
Oct 14, 2019
Sou Teas Extension Received
Aug 23, 2019
Notice Of Approval Of Extension Request E-Mailed
Aug 22, 2019
Sou Extension 3 Granted
Apr 17, 2019
Sou Extension 3 Filed
Aug 14, 2019
Notice Of Revival - E-Mailed
Aug 14, 2019
Sou Extension Received With Teas Petition
Aug 14, 2019
Petition To Revive-Granted
Aug 14, 2019
Teas Petition To Revive Received
May 20, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
May 20, 2019
Abandonment - No Use Statement Filed
Mar 13, 2019
Notice Of Approval Of Extension Request E-Mailed
Mar 12, 2019
Sou Extension 2 Granted
Oct 17, 2018
Sou Extension 2 Filed
Mar 8, 2019
Case Assigned To Intent To Use Paralegal
Feb 21, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 21, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 17, 2019
Notice Of Revival - E-Mailed
Jan 16, 2019
Sou Extension Received With Teas Petition
Jan 16, 2019
Petition To Revive-Granted
Jan 16, 2019
Teas Petition To Revive Received
Nov 19, 2018
Abandonment Notice Mailed - No Use Statement Filed
Nov 19, 2018
Abandonment - No Use Statement Filed
Oct 1, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 1, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 1, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 1, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 24, 2018
Notice Of Approval Of Extension Request E-Mailed
Feb 22, 2018
Sou Extension 1 Granted
Feb 22, 2018
Sou Extension 1 Filed
Feb 22, 2018
Sou Teas Extension Received
Oct 17, 2017
Noa E-Mailed - Sou Required From Applicant
Aug 22, 2017
Official Gazette Publication Confirmation E-Mailed
Aug 22, 2017
Published For Opposition
Aug 2, 2017
Notification Of Notice Of Publication E-Mailed
Jul 17, 2017
Approved For Pub - Principal Register
Jul 10, 2017
Assigned To Examiner
Apr 21, 2017
Notice Of Pseudo Mark E-Mailed
Apr 20, 2017
New Application Office Supplied Data Entered
Apr 17, 2017
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24